Amylou Dueck

39PUBLICATIONS
356CO-AUTHORS
Haematological tumoursInnate immunityClinical psychologyPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Oct 13, 2026
Molecular Consequences and Targeting of PPM1D Overexpression in Myeloproliferative Neoplasms.

|Sep 16, 2026
Type 1 interferon perturbates clonal competition by reshaping human blood development.

|Jul 28, 2026
Psychometric Evaluation of the PRO-CTCAE Average Composite Score: Reliability, Responsiveness, Known-Groups Validity, and Sensitivity to Group Differences.

|Jul 27, 2026
Self-reported geriatric impairments and treatment toxicity in older patients with multiple myeloma.

|May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39).

|Jan 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck

Pageof 7

Frequent Collaborators

14 joint publications

Ethan Basch

6 joint publications

Antonia V Bennett

6 joint publications

Allison M Deal

5 joint publications

Gina L Mazza